Lackner Mark

Chief Scientific Officer at ZNTL; SVP, Head of Biology at IDYA

Sold, on record
$261k
Dollars the filings state
Form 4 sales
7
Latest Feb 3, 2025
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • ZNTLZentalis Pharmaceuticals, Inc.Chief Scientific Officer
  • IDYAIDEAYA Biosciences, Inc.SVP, Head of Biology

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale IDYAUnusual
    Jun 17, 2020 2020

    Sold 7,123 shares at $15.19 ($108k)

    Lackner Mark, SVP, Head of Biology

    Sold 100% of holdings ($108k position)0 shares leftFiling

  2. 2 Form 4 sale IDYAUnusual
    Jan 26, 2021 +223 days

    Sold 2,501 shares at $18.46 ($46k)

    Lackner Mark, SVP, Head of Biology

    Sold 100% of holdings ($46k position)0 shares leftFiling

  3. 3 Form 4 sale IDYAUnusual
    Feb 10, 2021 +15 days

    Sold 2,000 shares at $21.03 ($42k)

    Lackner Mark, SVP, Head of Biology

    Sold 100% of holdings ($42k position)0 shares left0.8x usual sizeFiling

  4. 4 Form 144 notice ZNTLNotice
    Feb 2, 2024 +1087 days

    Filed to sell 1,585 shares ($18k)

    Lackner Mark, Chief Scientific Officer

    No 10b5-1 planFirst sale on recordFiling

  5. 5 Form 4 sale ZNTLNo plan
    Feb 2, 2024 same day

    Sold 1,585 shares at $11.54 ($18k)

    Lackner Mark, Chief Scientific Officer

    No 10b5-1 planSold 0.8% of holdings ($2.3M position)195,728 shares leftFirst sale on recordFollows a Form 144Filing

  6. 6 Form 4 sale ZNTLNo plan
    Jan 2, 2025 +335 days

    Sold 4,411 shares at $3.12 ($14k)

    Lackner Mark, Chief Scientific Officer

    No 10b5-1 planSold 2.3% of holdings ($611k position)191,317 shares leftFiling

  7. 7 Form 144 notice ZNTLNotice
    Feb 3, 2025 +32 days

    Filed to sell 14,368 shares ($25k)

    Lackner Mark, Chief Scientific Officer

    No 10b5-1 planFiling

  8. 8 Form 4 sale ZNTLNo plan
    Feb 3, 2025 same day

    Sold 14,368 shares at $1.71 ($25k)

    Lackner Mark, Chief Scientific Officer

    No 10b5-1 planSold 2.7% of holdings ($902k position)512,856 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Lackner Mark
Source
Feb 3, 2025Feb 5, 2025ZNTLChief Scientific OfficerForm 4 sale14,368$25k2.7%No planSEC
Feb 3, 2025Feb 3, 2025ZNTLChief Scientific OfficerForm 144 notice14,368$25kNoticeSEC
Jan 2, 2025Jan 3, 2025ZNTLChief Scientific OfficerForm 4 sale4,411$14k2.3%No planSEC
Feb 2, 2024Feb 5, 2024ZNTLChief Scientific OfficerForm 4 sale1,585$18k0.8%No planSEC
Feb 2, 2024Feb 2, 2024ZNTLChief Scientific OfficerForm 144 notice1,585$18kNoticeSEC
Feb 10, 2021Feb 10, 2021IDYASVP, Head of BiologyForm 4 sale2,000$42k100.0%UnusualSEC
Jan 26, 2021Jan 28, 2021IDYASVP, Head of BiologyForm 4 sale2,501$46k100.0%UnusualSEC
Jun 17, 2020Jun 18, 2020IDYASVP, Head of BiologyForm 4 sale7,123$108k100.0%UnusualSEC
Jun 2, 2020Jun 4, 2020IDYASVP, Head of BiologyForm 4 sale845$8k100.0%UnusualSEC